Atıf Formatları
The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: in vitro study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

D. Colpan Oksuz Et Al. , "The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: in vitro study," EJC SUPPLEMENTS , vol.3, no.2, pp.254, 2005

Colpan Oksuz, D. Et Al. 2005. The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: in vitro study. EJC SUPPLEMENTS , vol.3, no.2 , 254.

Colpan Oksuz, D., Oner Dincbas, F., Atalar, B., Altug, T., Ilvan, S., Uzun, H., ... Gedik, N.(2005). The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: in vitro study. EJC SUPPLEMENTS , vol.3, no.2, 254.

Colpan Oksuz, D. Et Al. "The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: in vitro study," EJC SUPPLEMENTS , vol.3, no.2, 254, 2005

Colpan Oksuz, D. C. Et Al. "The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: in vitro study." EJC SUPPLEMENTS , vol.3, no.2, pp.254, 2005

Colpan Oksuz, D. Et Al. (2005) . "The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: in vitro study." EJC SUPPLEMENTS , vol.3, no.2, p.254.

@article{article, author={D. Colpan Oksuz Et Al. }, title={The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: in vitro study}, journal={EJC SUPPLEMENTS}, year=2005, pages={254} }